pharmaphorum

OCTOBER 26, 2020

Preventive care programmes are key to better health outcomes, but several factors are limiting their uptake. A new analysis looks at these barriers and asks how they could be overcome. Over the past decade, many healthcare systems have worked to expand their focus on health maintenance and disease prevention as several studies have indicated that preventive care services can play a significant role in improving general health while helping reduce long term healthcare costs.

Vaccines 128

Vaccines 128

Outsourcing Pharma

OCTOBER 30, 2020

In order to effectively handle collection and analysis of huge volumes of vital data, a leader from IQVIA advises bringing on people up to the challenge.

122

122

Pharma Times

OCTOBER 28, 2020

Acquisition will enable Base Genomics to accelerate clinical and commercial development

141

141

Drug Patent Watch

OCTOBER 24, 2020

Annual Drug Patent Expirations for TYZEKA Tyzeka is a drug marketed by Novartis and is included in two NDAs. There are three patents protecting this drug. This drug has fifty-five…. The post New patent expiration for Novartis drug TYZEKA appeared first on DrugPatentWatch - Make Better Decisions.

72

72

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

OCTOBER 30, 2020

Since entering the pharmaceutical industry as a graduate trainee in the late 1990s, Asad Mohsin Ali’s career has taken him across the business from Novartis, MSD and Tesaro, before joining global biopharma Ipsen. He tells us how the company has responded to COVID and how he’d like to see the UK industry grow in the future. As managing director, Ipsen UK & Ireland, Ali heads up one of Ipsen’s three global hubs, as well as chairing a UK & Ireland Site Steering Committee overseeing 900 peop

Hospitals 125

Hospitals Pharmaceutical Companies Pharmaceutical Companies 125

Outsourcing Pharma

OCTOBER 26, 2020

The agency has approved the antiviral drug Veklury (remdesivir), produced by Gilead, for hospitalized patients 12 years and over diagnosed with the virus.

Hospitals 105

Hospitals 105

NY Times

OCTOBER 29, 2020

Gilead Sciences said Wednesday that remdesivir, which has been authorized for emergency use since the spring, brought in $873 million in revenues so far this year.

74

74

pharmaphorum

OCTOBER 28, 2020

Claus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks what a truly effective feedback loop for medicines might look like. The democratisation of data opens up improvements to virtually every product and service across virtually every sector — bar one. Pharma remains stubbornly closed to feedback, with potentially damaging consequences for the industry, healthcare systems and patients.

Vaccines 117

Vaccines Hospitals Pharmaceutical Companies Pharmaceutical Companies 117

Outsourcing Pharma

OCTOBER 26, 2020

A leader from the drug research and development company discusses unique problems faced by COVID-19 patients with prior cancer and autoimmune diagnoses.

105

105

Pharma Times

OCTOBER 30, 2020

Drug significantly eliminated oral corticosteroid (OCS) in OCS-dependent asthma patients

114

114

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Drug Patent Watch

OCTOBER 25, 2020

Annual Drug Patent Expirations for CIALIS Cialis is a drug marketed by Lilly and is included in one NDA. It is available from seven suppliers. There is one patent protecting…. The post New patent expiration for LILLY drug CIALIS appeared first on DrugPatentWatch - Make Better Decisions.

64

64

pharmaphorum

OCTOBER 27, 2020

Analysing real-world health data could help overcome the bias towards men in traditional medical research, says Sensyne Health’s Dr Lucy Mackillop. Collecting and analysing anonymised patient data has the potential to generate valuable insights that can catalyse research, lead to improved patient care, and power the development of new treatments.

Diabetes 113

Diabetes Medical Records Hospitals 113

Outsourcing Pharma

OCTOBER 30, 2020

This year the conference brings its content, focused on the intersection of clinical research and patient care, from the real world to the virtual one.

96

96

Pharma Times

OCTOBER 26, 2020

Trial will investigate chemotherapy drug to alleviate hallucinations in people with Parkinson’s

Chemotherapy 105

Chemotherapy 105

Drug Patent Watch

OCTOBER 30, 2020

Annual Drug Patent Expirations for ELLA Ella is a drug marketed by Lab Hra Pharma and is included in one NDA. It is available from one supplier. There are seven…. The post New patent for Lab Hra drug ELLA appeared first on DrugPatentWatch - Make Better Decisions.

59

59

pharmaphorum

OCTOBER 26, 2020

Moderna is close to completing its phase 3 trial of COVID-19 vaccine candidate mRNA-1273 after completing recruitment of the 30,000 subjects in the trial. It’s also revealed that more than 25,000 of them have already received the second dose of the shot in the COVE study , putting it in contention to be the first coronavirus vaccine company to be ready to file for emergency use authorisation in the US.

Vaccines 109

Vaccines Diabetes 109

Outsourcing Pharma

OCTOBER 27, 2020

The clinical research solutions firm is joining forces with pharma giant Eli Lilly to manage mobile research of the monoclonal antibody LY-CoV555.

98

98

Pharma Times

OCTOBER 27, 2020

Trial was paused in September following participant illness

Vaccines 128

Vaccines 128

Drug Patent Watch

OCTOBER 30, 2020

Annual Drug Patent Expirations for OSMOLEX+ER Osmolex Er is a drug marketed by Osmotica Pharm and is included in one NDA. It is available from one supplier. There are eight…. The post New patent for Osmotica Pharm drug OSMOLEX ER appeared first on DrugPatentWatch - Make Better Decisions.

59

59

pharmaphorum

OCTOBER 27, 2020

Eli Lilly says no more patients will be treated with its COVID-19 therapy bamlanivimab in a trial run by the US National Institute of Allergy and Infectious Diseases (NIAID), as results to date suggest it is unlikely to be effective. The ACTIV-3 study was comparing bamlanivimab (also known as LY-CoV555 or LY3819253) and placebo when added to therapy with Gilead Sciences’ Veklury (remdesivir), which is already approved to treat COVID-19 requiring hospitalisation.

Nursing Homes 104

Nursing Homes 104

Outsourcing Pharma

OCTOBER 30, 2020

During the CRAACO conference, a leader from the study solutions firm will discuss how researchers can learn and benefit from the other industry.

96

96

Pharma Times

OCTOBER 30, 2020

Findings come from new research funded by Cancer Research UK and NIHR

109

109

NY Times

OCTOBER 27, 2020

With state and city government support, developers are building laboratories for medical research and incubator spaces for biotech start-ups amid the race for a coronavirus vaccine.

Vaccines 56

Vaccines 56

pharmaphorum

OCTOBER 26, 2020

Bayer’s blockbuster ambitions for diabetic kidney disease (DKD) drug candidate finerenone look a lot firmer with the publication of data from the phase 3 FIDELIO-DKD trial. Bayer teased the top-line result from the study back in July, providing the first clue that its sizeable investment in the finerenone programme could pay off, but kept the data under wraps other than to say the drug met the dual objectives of reducing renal and cardiovascular events in patients with type 2 diabetes and chroni

Diabetes 98

Diabetes 98

Drug Patent Watch

OCTOBER 30, 2020

Annual Drug Patent Expirations for CRESEMBA Cresemba is a drug marketed by Astellas and is included in two NDAs. It is available from one supplier. There are two patents protecting…. The post New patent expiration for Astellas drug CRESEMBA appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

OCTOBER 28, 2020

Process can help to reduce the time to authorisation of the vaccine

Vaccines 108

Vaccines 108

Pharma Marketing Network

OCTOBER 30, 2020

October 22, 2020 eHealthcare Solutions hosted their 90@90 webinar, Video…The New Now. Throughout the webinar, EVP, Partner Development of eHealthcare Solutions, Gail Jaeger-Law, covers three different topics including, what has changed and what has remained the same during COVID-19, the current state of the industry including shifts and changes, and growth in the digital landscape including video.

52

52

pharmaphorum

OCTOBER 27, 2020

US biotech BioSig Technologies has abandoned a phase 2 trial of its antiviral drug merimepodib with Gilead’s Veklury in severe COVID-19 patients, after concluding the safety of the combination was in doubt. Shares in the company plunged more than 40% on the Nasdaq after the announcement, which revealed a difference in survival rates between the two groups enrolled into the study.

Hospitals 98

Hospitals 98

Drug Patent Watch

OCTOBER 30, 2020

Annual Drug Patent Expirations for VEREGEN Veregen is a drug marketed by Fougera Pharms Inc and is included in one NDA. It is available from one supplier. There are four…. The post New patent expiration for Fougera Pharms drug VEREGEN appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

OCTOBER 28, 2020

Agreement will see vaccine developers make available 200 million doses

Vaccines 95

Vaccines 95

Pharma Mirror

OCTOBER 30, 2020

The sneeze guard has been keeping employees at public counters, and food on display, safe from contagious diseases for a long time now, so it’s most certainly not a new invention. However, the need to install a sneeze guard in hospitals, pharmacies and other healthcare facilities is an absolute must in 2020 and beyond. Keeping. The post Why Sneeze Guards are Not Optional Anymore appeared first on Pharma Mirror Magazine.

Hospitals 52

Hospitals 52

pharmaphorum

OCTOBER 28, 2020

The US government said it will buy 300,000 doses of Eli Lilly’s COVID-19 therapy bamlanivimab for $375 million if the drug gets Emergency Use Authorisation (EUA) – although its effectiveness has been called into question. The initial agreement is for delivery over the two months following an EUA, and provides the option for the government to purchase up to an additional 650,000 vials through 30 June 2021.

Nursing Homes 90

Nursing Homes 90

Drug Patent Watch

OCTOBER 30, 2020

Annual Drug Patent Expirations for OCALIVA Ocaliva is a drug marketed by Intercept Pharms Inc and is included in one NDA. It is available from one supplier. There are eight…. The post New patent for Intercept Pharms drug OCALIVA appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

OCTOBER 29, 2020

Agreement will also see companies develop treatments for frontotemporal dementia

94

94

Pharma Mirror

OCTOBER 30, 2020

Leading cloud temperature management solutions provider, TSS Middle East, today announces the appointment of Christopher Hobeiche as the new regional manager for their Middle East operations. Christopher Hobeiche joined the TSS Middle East Africa team earlier this month as part of strategic efforts to strengthen company operations in the region. TSS provides temperature monitoring solutions.

52

52